fbpx Skip to main content

THURSDAY, April 8, 2021 (HealthDay News) — More than half a million people have gained health coverage under a special sign-up window for Affordable Care Act (ACA) insurance plans, the White House said Wednesday.

Officials said even more Americans will get insurance under the sign-up opportunity that will be available until Aug. 15 because millions became eligible as of April 1 for increased subsidies toward their premiums, the Associated Press reported.

As the number of uninsured increased during the COVID-19 pandemic, President Joe Biden reopened the ACA insurance markets. That was followed by the COVID-19 relief package that increased subsidies for insurance premiums and expanded the number of people who qualified for financial assistance, the AP reported. Those measures will be in place through the end of 2022.

Consumers who were already enrolled at the beginning of this year are also entitled to the increased financial aid but will have to go online or call to update their plan, the AP reported. On average, people could save $50 a month, the government said.

The enrollment numbers released Wednesday by the U.S. Centers for Medicare & Medicaid Services show that 528,005 people signed up for government-sponsored private insurance plans between Feb. 15 and March 31. But those figures only cover the 36 states served by the federal HealthCare.gov insurance market. National enrollment will be higher when totals are factored in later on from states such as California and New York that run their own insurance websites, the AP reported.

The new report also showed that more than 870,000 people who went to the HealthCare.gov website or reached out to the call center were found to be eligible for Medicaid, the federal-state health program for low-income people. Among the states showing strong gains in enrollment were Florida, Texas, and North Carolina. Florida recorded the biggest gain, with more than 146,000 sign-ups.

You May Also Like::  Oral L-Glutamine for Sickle Cell Disease

Associated Press Article

“Keeping up with the indications and adverse reactions to immune checkpoint inhibitors can be a full-time job. Cutaneous side effects occur in up to 45% of patients treated with ipilimumab and 34% of patients treated with nivolumab and pembrolizumab.” https://bit.ly/3FGtxtd

.@spfnomt: This month’s #DermWorld article “Estate planning 101” is especially important for young physicians to read. The long, all-consuming years between adolescence and physicianhood can become a blur...https://bit.ly/3FxOtCv

That’s a wrap #AAD2023! 5 days of soaking up knowledge from dermatologists on topics such as hidradenitis, melasma, & dietary triggers of common dermatoses.

I LOVED the #womenshealth focused sessions on vulvar dermatoses and pregnancy medication safety.

#dermtwitter
@AADmember

New approach uses microbiome to treat skin disease by repairing the injured microbiome that allowed inflammation to flare up in the first place, rather than reducing the inflammation after the fact. https://bit.ly/3Jt6H9v

Load More